Company profile: New View Surgical
1.1 - Company Overview
Company description
- Provider of minimally invasive surgical imaging and access systems, including the VisionPort System—a single-use solution combining a laparoscope, camera, light source, and access port to enhance efficiency and visualization—its Handpiece integrating multiple surgical tools for control and vision, and a Control Unit managing functions and workflow.
Products and services
- VisionPort System: A single-use system combining a laparoscope, camera, light source, and access port for minimally invasive surgery, enhancing surgical efficiency and visualization across MIS procedures
- VisionPort System Control Unit: A medical-grade control unit designed to manage VisionPort functions and enhance the surgical team's workflow during MIS, centralizing device control to streamline procedural efficiency
- VisionPort System Handpiece: A custom-engineered handpiece integrating multiple surgical tools into one device for improved surgical control and vision, enabling consolidated instrument use within the VisionPort System
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to New View Surgical
Osteogenics Biomedical
HQ: United States
Website
- Description: Provider of bone grafting products for periodontists, oral surgeons, and clinicians, including Cytoplast PTFE membranes for guided bone regeneration and soft tissue augmentation; enCore combination and mineralized allografts; Zcore porcine xenograft; Cytoplast RTM, Vitala, and Zmatrix collagen membranes for guided tissue regeneration in dental surgeries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Osteogenics Biomedical company profile →
Venclose
HQ: United States
Website
- Description: Provider of medical technology solutions for the treatment of chronic venous insufficiency, aiming to improve the physician and patient experience by commercializing RF therapy. Founded in 2014 and headquartered in San Jose, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Venclose company profile →
Iogyn
HQ: United States
Website
- Description: Provider of medical devices, offering the Symphion System for endoscopically controlled radiofrequency bipolar resection and removal of soft tissue—including uterine tissue, polyps, myomas, and prostate adenomas—under endoscopic visualization and continuous flow conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iogyn company profile →
Invuity
HQ: United States
Website
- Description: Provider of illumination and visualization products for minimally invasive surgical field applications, offering the BriteField Port System for illumination and visualization during minimally invasive procedures and the BriteField McCulloch retractor to achieve visualization during surgery while using traditional techniques.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invuity company profile →
NX Development
HQ: United States
Website
- Description: Provider of real-time intra-operative imaging agents. Offers Gleolan, an optical imaging agent used during brain tumor resection to visualize malignant tissue, and Phase 3 studies assessing Gleolan for detecting and visualizing meningiomas (MEN-301) and investigating its real-time detection and visualization of ovarian cancer during debulking surgery (OVA-302).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NX Development company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for New View Surgical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to New View Surgical
2.2 - Growth funds investing in similar companies to New View Surgical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for New View Surgical
4.2 - Public trading comparable groups for New View Surgical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →